![John Egan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Mark Bruzzi | M | - |
Vetex Medical Ltd.
![]() Vetex Medical Ltd. Medical SpecialtiesHealth Technology Part of Surmodics, Inc., Vetex Medical Ltd. is a medical company based in Galway, Ireland. The Irish company's first innovation is the Revene thrombectomy catheter, which is specifically engineered for the treatment of venous disease. The catheter is 510(k) cleared by the FDA for mechanical de-clotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature. The company was founded by Mark Bruzzi, who has been the CEO since incorporation. Vetex Medical was acquired by SurModics MD LLC on July 06, 2021 for $59.78 million. | - |
Bernard E. Lyons | M | - |
Vetex Medical Ltd.
![]() Vetex Medical Ltd. Medical SpecialtiesHealth Technology Part of Surmodics, Inc., Vetex Medical Ltd. is a medical company based in Galway, Ireland. The Irish company's first innovation is the Revene thrombectomy catheter, which is specifically engineered for the treatment of venous disease. The catheter is 510(k) cleared by the FDA for mechanical de-clotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature. The company was founded by Mark Bruzzi, who has been the CEO since incorporation. Vetex Medical was acquired by SurModics MD LLC on July 06, 2021 for $59.78 million. | - |
Sean Morris | M | 52 |
Vetex Medical Ltd.
![]() Vetex Medical Ltd. Medical SpecialtiesHealth Technology Part of Surmodics, Inc., Vetex Medical Ltd. is a medical company based in Galway, Ireland. The Irish company's first innovation is the Revene thrombectomy catheter, which is specifically engineered for the treatment of venous disease. The catheter is 510(k) cleared by the FDA for mechanical de-clotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature. The company was founded by Mark Bruzzi, who has been the CEO since incorporation. Vetex Medical was acquired by SurModics MD LLC on July 06, 2021 for $59.78 million. | - |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
País | Relaciones | % del total |
---|---|---|
Irlanda | 3 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- John Egan
- Red Personal